LIFEMD, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- LIFEMD, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-03-31 was 1.25K shares.
- LIFEMD, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2023-12-31 was -36.87K shares, a 160.74% decline year-over-year.
- LIFEMD, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2023-09-30 was 57.90K shares, a 1293.19% increase year-over-year.
- LIFEMD, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2022-12-31 was 60.71K shares.
- LIFEMD, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 37.50K shares, a 58.52% decline from fiscal 2022.
- LIFEMD, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 90.40K shares, a 75.89% decline from fiscal 2021.
- LIFEMD, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2021 was 375.00K shares, a 29.99% decline from fiscal 2020.
- LIFEMD, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2020 was 535.60K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2024-03-31 | 1.25K shares 10-Q · filed 2024-05-08 | |
| 2023-12-31 | -36.87K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | 37.50K shares 10-K · filed 2024-03-11 |
| 2023-09-30 | 57.90K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | |
| 2022-12-31 | 60.71K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | 90.40K shares 10-K · filed 2024-03-11 |
| 2022-09-30 | 4.16K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | |
| 2022-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | |
| 2022-03-31 | 25.54K shares 10-Q · filed 2022-05-13 | |
| 2021-12-31 | 375.00K shares 10-K · filed 2023-03-22 | |
| 2020-12-31 | 535.60K shares 10-K · filed 2022-03-07 | |
| 2013-12-31 | 50.00K shares 10-K · filed 2015-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| SBC Medical Group Holdings Inc (SBC) | United States | $0.487B | |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |